Timothy L Pruett

Timothy L Pruett is a Professor in the Department of Surgery and holds a secondary appointment in the Division of Gastroenterology, Hepatology and Nutrition within the Department of Medicine at the University of Minnesota Medical School. His primary focus is transplant surgery, specializing in liver and pancreas transplantation, with significant contributions to clinical practice and research in organ transplantation.

Dr. Pruett's research spans critical areas in transplantation medicine, with primary interests in Transplant Surgery focusing on Liver Transplantation and Pancreas Transplantation. He investigates Transplant Infectious Diseases and Transplant Immunology, particularly vaccine responses in immunocompromised patients, and applies advanced technologies to improve Surgical Outcomes. His fingerprint analysis highlights expertise in pancreatectomy, liver transplantation, infection management, and autotransplantation.

His 2025 publications demonstrate a strong emphasis on advancing liver transplantation through predictive modeling, AI-driven sarcopenia assessment, and infectious disease management. Key trends include developing clinical decision tools like MELDPredict, optimizing vaccine strategies for transplant recipients, and improving organ preservation techniques.

Scientific Awards:

• No awards listed in the provided information.

Research Grants:

Dr. Pruett leads multiple active research projects funded by NIH, NSF, and industry partners:

• CMVIG prophylaxis in belatacept conversion kidney transplant recipients: KAMADA, INC. (2024-2034)
• Cryopreservation and nanowarming for whole liver banking: NIH-funded (2023-2027)
• NetEthics: Responsible Conduct in Research Networks: NSF project (2022-2025)
• Timed Measurements of Plasma Iohexol Clearance: American Society of Transplant Surgeons (2023-2024)
• Safety of SARS-COVID-19 Vaccine in Transplant Recipients: NATERA, INC. (2021-2022)

With 16 total projects (3 active, 13 completed), his work demonstrates leadership in clinical innovation and transplantation science.

Laboratory Affiliation:

Dr. Pruett is integral to the Advanced Technologies for Preservation of Biological Systems (ATP-BIO) initiative, which develops cutting-edge organ preservation methods through interdisciplinary collaboration between engineers, clinicians, and scientists.